CN116004548A - 一种基于外泌体递送microRNA制备诱导性多能干细胞的方法 - Google Patents
一种基于外泌体递送microRNA制备诱导性多能干细胞的方法 Download PDFInfo
- Publication number
- CN116004548A CN116004548A CN202310265349.7A CN202310265349A CN116004548A CN 116004548 A CN116004548 A CN 116004548A CN 202310265349 A CN202310265349 A CN 202310265349A CN 116004548 A CN116004548 A CN 116004548A
- Authority
- CN
- China
- Prior art keywords
- micrornas
- exosome
- stem cells
- pluripotent stem
- induced pluripotent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000001808 exosome Anatomy 0.000 title claims abstract description 107
- 238000000034 method Methods 0.000 title claims abstract description 56
- 239000002679 microRNA Substances 0.000 title claims abstract description 49
- 108700011259 MicroRNAs Proteins 0.000 title claims abstract description 29
- 210000004263 induced pluripotent stem cell Anatomy 0.000 title claims abstract description 24
- 108091070501 miRNA Proteins 0.000 claims abstract description 58
- 238000011068 loading method Methods 0.000 claims abstract description 10
- 230000008672 reprogramming Effects 0.000 claims abstract description 7
- 238000010367 cloning Methods 0.000 claims abstract description 4
- 210000004027 cell Anatomy 0.000 claims description 88
- 238000001890 transfection Methods 0.000 claims description 34
- 239000000126 substance Substances 0.000 claims description 17
- 239000006228 supernatant Substances 0.000 claims description 14
- 241000700605 Viruses Species 0.000 claims description 11
- 239000001963 growth medium Substances 0.000 claims description 11
- 150000003384 small molecules Chemical class 0.000 claims description 10
- 239000013612 plasmid Substances 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 8
- 239000002609 medium Substances 0.000 claims description 8
- 239000012228 culture supernatant Substances 0.000 claims description 7
- 239000008188 pellet Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 210000005260 human cell Anatomy 0.000 claims description 5
- 238000004520 electroporation Methods 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims description 3
- 108091050113 miR-211 stem-loop Proteins 0.000 claims description 3
- 108091023108 miR-30e stem-loop Proteins 0.000 claims description 3
- 108091027549 miR-30e-1 stem-loop Proteins 0.000 claims description 3
- 108091029213 miR-30e-2 stem-loop Proteins 0.000 claims description 3
- 108091085488 miR-30e-3 stem-loop Proteins 0.000 claims description 3
- 108091041877 miR-519d stem-loop Proteins 0.000 claims description 3
- 108091086222 miR-520c stem-loop Proteins 0.000 claims description 3
- 210000001728 clone cell Anatomy 0.000 claims description 2
- 210000004251 human milk Anatomy 0.000 claims description 2
- 108091024082 miR-32 stem-loop Proteins 0.000 claims description 2
- 108091062587 miR-32-1 stem-loop Proteins 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 238000000527 sonication Methods 0.000 claims description 2
- 230000006698 induction Effects 0.000 abstract description 9
- 238000005516 engineering process Methods 0.000 abstract description 8
- 238000004113 cell culture Methods 0.000 abstract description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 abstract description 2
- 230000005779 cell damage Effects 0.000 abstract 1
- 208000037887 cell injury Diseases 0.000 abstract 1
- 239000002502 liposome Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 239000000725 suspension Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 9
- 108091023040 Transcription factor Proteins 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 102000040945 Transcription factor Human genes 0.000 description 6
- 108010082117 matrigel Proteins 0.000 description 6
- 238000007747 plating Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000038379 digestive enzymes Human genes 0.000 description 5
- 108091007734 digestive enzymes Proteins 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 4
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 239000012124 Opti-MEM Substances 0.000 description 2
- 101150037203 Sox2 gene Proteins 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000002659 cell therapy Methods 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 210000001778 pluripotent stem cell Anatomy 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- AQGNHMOJWBZFQQ-UHFFFAOYSA-N CT 99021 Chemical compound CC1=CNC(C=2C(=NC(NCCNC=3N=CC(=CC=3)C#N)=NC=2)C=2C(=CC(Cl)=CC=2)Cl)=N1 AQGNHMOJWBZFQQ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000031448 Genomic Instability Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 241000711408 Murine respirovirus Species 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- WRKPZSMRWPJJDH-UHFFFAOYSA-N N-(6-methyl-1,3-benzothiazol-2-yl)-2-[(4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)thio]acetamide Chemical compound S1C2=CC(C)=CC=C2N=C1NC(=O)CSC1=NC=2CCSC=2C(=O)N1C1=CC=CC=C1 WRKPZSMRWPJJDH-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- -1 PD0325901 Chemical compound 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000003307 reticuloendothelial effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310265349.7A CN116004548B (zh) | 2023-03-20 | 2023-03-20 | 一种基于外泌体递送microRNA制备诱导性多能干细胞的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310265349.7A CN116004548B (zh) | 2023-03-20 | 2023-03-20 | 一种基于外泌体递送microRNA制备诱导性多能干细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116004548A true CN116004548A (zh) | 2023-04-25 |
CN116004548B CN116004548B (zh) | 2023-09-08 |
Family
ID=86032052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310265349.7A Active CN116004548B (zh) | 2023-03-20 | 2023-03-20 | 一种基于外泌体递送microRNA制备诱导性多能干细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116004548B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109750068A (zh) * | 2019-01-29 | 2019-05-14 | 兰州大学 | 一种使外泌体携带外源microRNA的方法 |
CN113136362A (zh) * | 2020-01-20 | 2021-07-20 | 医微细胞生物技术(广州)有限公司 | 一种囊泡及其应用 |
TW202140783A (zh) * | 2020-04-29 | 2021-11-01 | 希龍 林 | 活體外誘導多潛能性幹細胞增殖及分化 |
CN115141804A (zh) * | 2022-09-05 | 2022-10-04 | 南京鼓楼医院 | 一种基于脂肪外泌体的神经元转染方法及其应用 |
CN116004512A (zh) * | 2022-12-30 | 2023-04-25 | 深圳市康宁医院 | 一种利用外泌体制备诱导性多能干细胞的方法及其试剂和应用 |
-
2023
- 2023-03-20 CN CN202310265349.7A patent/CN116004548B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109750068A (zh) * | 2019-01-29 | 2019-05-14 | 兰州大学 | 一种使外泌体携带外源microRNA的方法 |
CN113136362A (zh) * | 2020-01-20 | 2021-07-20 | 医微细胞生物技术(广州)有限公司 | 一种囊泡及其应用 |
TW202140783A (zh) * | 2020-04-29 | 2021-11-01 | 希龍 林 | 活體外誘導多潛能性幹細胞增殖及分化 |
CN115141804A (zh) * | 2022-09-05 | 2022-10-04 | 南京鼓楼医院 | 一种基于脂肪外泌体的神经元转染方法及其应用 |
CN116004512A (zh) * | 2022-12-30 | 2023-04-25 | 深圳市康宁医院 | 一种利用外泌体制备诱导性多能干细胞的方法及其试剂和应用 |
Non-Patent Citations (2)
Title |
---|
SHELLEY E S SANDMAIER: "MicroRNA-Mediated Reprogramming of Somatic Cells into Induced Pluripotent Stem Cells", METHODS IN MOLECULAR BIOLOGY, vol. 1330, pages 3 * |
陈俏羽;赵丽华;陈袁;张曼玲;侯道荣;姜海滨;王俊政;刘曼菱;王晨宇;尤志欢;李荣凤;: "miRNA-205过表达载体的构建及其对猪诱导性多能干细胞建系的作用", 南京医科大学学报(自然科学版), no. 06 * |
Also Published As
Publication number | Publication date |
---|---|
CN116004548B (zh) | 2023-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019228108A1 (zh) | 用于提高细胞转染效率的试剂组合物 | |
CN115141804B (zh) | 一种基于脂肪外泌体的神经元转染方法及其应用 | |
CN109402062A (zh) | Zip1基因在制备抑制骨髓间充质干细胞凋亡的产品中的应用 | |
CN116004548B (zh) | 一种基于外泌体递送microRNA制备诱导性多能干细胞的方法 | |
CN110075122B (zh) | 一种肝癌治疗性外泌体药物 | |
CN113528432A (zh) | 一种利用miR-18抑制剂促牛成肌细胞分化的方法 | |
CN112094814A (zh) | 一种通过灌流培养工艺制备腺病毒载体疫苗的方法 | |
CN111254110A (zh) | 一种将间充质干细胞转分化为精子的方法 | |
CN115449525A (zh) | 一种提高腺病毒转染巨噬细胞效率的方法 | |
CN110628712B (zh) | 基于诱导多能干细胞的治疗级间充质干细胞制备方法及应用 | |
CN115975949B (zh) | 一种基于microRNA制备诱导性多能干细胞的方法 | |
CN113106059A (zh) | 一种高迁徙间充质干细胞及其制备方法和应用 | |
CN112725377A (zh) | 白藜芦醇在电穿孔转染细胞中的应用及电转液 | |
CN106086069B (zh) | 一种转基因复合物及其制备方法与应用 | |
CN111150886B (zh) | 一种内皮化生物心脏瓣膜及其制备方法 | |
CN106190970B (zh) | 诱导脐带间充质干细胞直接转分化为红母细胞的方法 | |
CN112342239B (zh) | 褪黑素在电穿孔转染细胞中的应用 | |
CN112280859B (zh) | 一种乳腺癌标志物及应用 | |
CN115252555B (zh) | 一种膜融合性脂质体、制备方法及其在蛋白质递送中的应用 | |
CN115975916B (zh) | circIGF1R在促进猪骨骼肌卫星细胞成肌分化中的应用 | |
CN109852637B (zh) | 一种提高腺相关病毒转染效率的方法 | |
CN118240765A (zh) | 一种提高干细胞耐受能力的方法 | |
CN105925606A (zh) | miR-34a生物纳米材料的构建方法及放射增敏应用 | |
CN108753731A (zh) | 一种bancr基因敲减稳转细胞、其构建方法和应用 | |
CN112322587A (zh) | 一种带Cas9基因的人源可诱导多能干细胞系、构建方法、鉴定方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 300452 building 20, Green Valley Health Industrial Park, No. 59, Kangtai Avenue, Binhai Science Park, high tech Zone, Binhai New Area, Tianjin Patentee after: Jiutian Lanyue Biotechnology (Tianjin) Co.,Ltd. Country or region after: China Address before: Building 20, Green Valley Health Industrial Park, No. 59 Kangtai Avenue, Binhai Science and Technology Park, Binhai High tech Zone, Tianjin, 300452 Patentee before: Tianjiu regenerative medicine (Tianjin) Technology Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |